667 related articles for article (PubMed ID: 32568015)
1. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Rajpoot K
Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting.
Handa M; Beg S; Shukla R; Barkat MA; Choudhry H; Singh KK
J Control Release; 2021 Dec; 340():48-59. PubMed ID: 34695523
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
6. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
Haider M; Abdin SM; Kamal L; Orive G
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127
[TBL] [Abstract][Full Text] [Related]
8. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
Nabi B; Rehman S; Baboota S; Ali J
AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
[TBL] [Abstract][Full Text] [Related]
9. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
10. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.
Yingchoncharoen P; Kalinowski DS; Richardson DR
Pharmacol Rev; 2016 Jul; 68(3):701-87. PubMed ID: 27363439
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
12. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy.
Chaudhuri A; Kumar DN; Shaik RA; Eid BG; Abdel-Naim AB; Md S; Ahmad A; Agrawal AK
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077466
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.
Carbone C; Cupri S; Leonardi A; Puglisi G; Pignatello R
Pharm Pat Anal; 2013 Sep; 2(5):665-77. PubMed ID: 24237173
[TBL] [Abstract][Full Text] [Related]
14. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
Teixeira MC; Carbone C; Souto EB
Prog Lipid Res; 2017 Oct; 68():1-11. PubMed ID: 28778472
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials.
Kabil MF; Badary OA; Bier F; Mousa SA; El-Sherbiny IM
J Liposome Res; 2024 Mar; 34(1):135-177. PubMed ID: 37144339
[TBL] [Abstract][Full Text] [Related]
16. Highlights in nanocarriers for the treatment against cervical cancer.
Medina-Alarcón KP; Voltan AR; Fonseca-Santos B; Moro IJ; de Oliveira Souza F; Chorilli M; Soares CP; Dos Santos AG; Mendes-Giannini MJS; Fusco-Almeida AM
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():748-759. PubMed ID: 28866224
[TBL] [Abstract][Full Text] [Related]
17. Lipid-Coated Nanosized Drug Delivery Systems for an Effective Cancer Therapy.
Esim O; Hascicek C
Curr Drug Deliv; 2021; 18(2):147-161. PubMed ID: 32394833
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib.
Korani M; Korani S; Zendehdel E; Jaafari MR; Sathyapalan T; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(6):643-650. PubMed ID: 31985384
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications.
Maddiboyina B; Ramaiah ; Nakkala RK; Roy H
Chem Biol Drug Des; 2023 Aug; 102(2):377-394. PubMed ID: 36916008
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review.
Khodaverdi H; Zeini MS; Moghaddam MM; Vazifedust S; Akbariqomi M; Tebyaniyan H
Curr Drug Deliv; 2022; 19(10):1012-1033. PubMed ID: 35078396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
